Anthropic IPO: $2 Trillion Test for Its Benefit Trust

Anthropic's roadshow just got its strangest slide. The planned IPO — which could value the Claude maker at up to $2 trillion — is forcing the first public reckoning with the Long-Term Benefit Trust (LTBT), the external body that controls a majority of its board. No company has taken a governance structure like this public.

What happened

The Financial Times reports the trust holds zero equity, yet can appoint or dismiss a majority of Anthropic's seven directors — it selected four, including Netflix co-founder Reed Hastings. Its three current trustees (Neil Buddy Shah chairs; Ben Bernanke and Richard Fontaine fill seats under a five-member cap) get advance notice of major actions such as new model launches, meet weekly, and weighed in on the Mythos cybersecurity model's limited rollout and the dispute with the US government over automated weapons. Separately, Morgan Stanley and Goldman Sachs are close to landing the top IPO roles.

Why it matters

This is the first IPO where a self-appointed body outranks shareholders by design. Harvard law professor Jesse Fried calls it a "built-in conflict": profit-seeking investors fund the company, then guardians decide how much profit to sacrifice. Anthropic wants the LTBT to become a GAAP-style blueprint for AI governance — which means public-market investors are now beta-testing the template for every future frontier lab. The trust has operated purely advisory so far, drawing no red lines.

The kill switch

One escape hatch exists: an 85% shareholder supermajority can fire the trustees — a threshold that could loosen once shares trade publicly. The real stress test starts the day a $2 trillion market cap meets an earnings miss and a mission constraint at the same time.